← Portfolio Scout

Portfolio company

Immunohelix

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Deep TechDigital Health

About

Immunohelix develops immune cell-specific oligonucleotide delivery systems and therapeutics for pharmaceutical companies seeking targeted treatments for immunological diseases, infections, and cancers.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies